Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension

Journal of Human Hypertension volume 16, pages 509–516 (2002)Cite this article

Abstract

Arterial pathology is a major contributor to cardiovascular disease, morbidity and mortality. Women are at higher risk of cardiovascular disease after menopause. Arterial stiffness determined by pulse wave velocity, increases with age both in men and women, whereas arterial compliance in premenopausal women is greater than in men of similar age. This difference is lost in the postmenopausal years, with evidence of rapid decline in arterial compliance in the perimenopausal period. Loss of hormonal modulation is a likely explanation for reduced arterial compliance in postmenopausal women. Long-term treatment with hormone replacement therapy (HRT) may be expected to partially reverse the increase in arterial stiffness. The aim of the study was to analyse the effect of HRT on blood pressure and arterial compliance in postmenopausal women with arterial hypertension receiving hypotensive drugs. The results in the present study of postmenopausal women with mild to moderate arterial hypertension receiving HRT showed only a transient tendency towards lower blood pressure. In our study HRT was found to improve arterial compliance at 3 months after HRT, and the effect was maintained throughout 12 months. The increased arterial compliance in women receiving HRT was independent of blood pressure. In parallel with decreasing pulse wave velocity women receiving HRT had lower total and low-density lipoprotein cholesterol. The conclusions were that after 1 year HRT in postmenopausal women with arterial hypertension improves circadian blood pressure pattern, but it does not affect significantly blood pressure values and variability. The present study also shows that HRT significantly inhibits age-related rigidity of large arteries.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4

Similar content being viewed by others

References

  1. Stampfer MJ et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study N Engl J Med 1991; 325: 756–762

    Article  CAS  Google Scholar 

  2. Grodstein F et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 1996; 335: 453–461

    Article  CAS  Google Scholar 

  3. Ettinger B, Friedman GD, Bush T, Quesenberry CP . Reduced mortality associated with long term postmenopausal oestrogen therapy Obstet Gynaecol 1996; 87: 6–12

    Article  CAS  Google Scholar 

  4. Volterani M, Rosano G, Coats A . Estrogen acutely increases peripheral blood flow in postmenopausal women Am J Med 1995; 99: 119–122

    Article  Google Scholar 

  5. Lehmann ED . Clinical value of aortic pulse-wave velocity measurement Lancet 1999; 354: 528–529

    Article  CAS  Google Scholar 

  6. Rajkumar C et al. Hormonal therapy increases arterial compliance in postmenopausal women J Am Coll Cardiol 1997; 30: 350–356

    Article  CAS  Google Scholar 

  7. London GM et al. Influence of sex on arterial hemodynamics and blood pressure. Role of body height Hypertension 1995; 26: 514–519

    Article  CAS  Google Scholar 

  8. Asmar RG et al. Non-invasive evaluation of arterial abnormalities in hypertensivepatients J Hypertens 1997; 15 (Suppl 2): 99–107

    Article  Google Scholar 

  9. Lip GY, Beevers M, Churchill D, Beevers DG . Hormone replacement therapy and blood pressure in hypertensive women J Hum Hypertens 1994; 8: 491–494

    CAS  PubMed  Google Scholar 

  10. Modena MG et al. Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women Am J Hypertens 1999; 12: 1000–1008

    Article  CAS  Google Scholar 

  11. Szekacs B et al. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension Menopause 2000; 7: 31–35

    Article  CAS  Google Scholar 

  12. Timio M et al. ‘Non-dipper’ hypertensivepatients and progressive renal insufficiency: a 3 year longitudinal study Clin Nephrol 1995; 43: 382–387

    CAS  PubMed  Google Scholar 

  13. Verdecchia P et al. Altered circadian blood pressure profile and prognosis Blood Press Monit 1997; 2: 347–352

    CAS  PubMed  Google Scholar 

  14. Mercuro G et al. Estradiol 17B reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension Am J Hypertens 1998; 11: 909–911

    Article  CAS  Google Scholar 

  15. Butkevich A, Abraham C, Philips RA . Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women Am J Hypertens 2000; 13: 1039–1041

    Article  CAS  Google Scholar 

  16. Mancia G et al. Structural cardiovascular alterations and blood pressure variability in human hypertension J Hypertens 1995; 13 (Suppl 2): S7–S14

    Article  CAS  Google Scholar 

  17. Imthurn B et al. Differential effects of hormone replacement therapy on endogenous nitric oxide levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate J Clin Endocrinol Metab 1997; 82: 388–394

    CAS  PubMed  Google Scholar 

  18. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 1995; 273: 199–208

  19. Blacher J et al. Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril Cardiovasc Drugs Ther 1998; 12: 409–414

    Article  CAS  Google Scholar 

  20. McGrath BP et al. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy Arterioscler Thromb Vasc Biol 1998; 18: 1149–1156

    Article  CAS  Google Scholar 

  21. Giraud GD et al. Effects of estrogen and progestin on aortic size and compliance in postmenopausal women Am J Obstet Gynecol 1996; 174: 1708–1716

    Article  CAS  Google Scholar 

  22. Nagai Y et al. Influence of age and postmenopausal estrogen replacement therapy on carotid arterial stiffness in women Cardiovasc Res 1999; 41: 307–311

    Article  CAS  Google Scholar 

  23. Angerer P, Kothny W, Stõrk S, von Schacky C . Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial J Am Coll Cardiol 2000; 36: 1789–1796

    Article  CAS  Google Scholar 

  24. Teede HJ et al. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function J Am Coll Cardiol 1999; 34: 131–137

    Article  CAS  Google Scholar 

  25. Failla M et al. Effects of cigarette smoking on carotid and arterial artery distensibility J Hypertens 1997; 15: 1659–1664

    Article  CAS  Google Scholar 

  26. Kool MJ et al. Short-and long-term effects of smoking on arterial wall properties in habitual smokers J Am Coll Cardiol 1993; 22: 1881–1886

    Article  CAS  Google Scholar 

  27. Gilligan DM et al. Acute vascular effects of estrogen in postmenopausal women Circulation 1994; 90: 786–791

    Article  CAS  Google Scholar 

  28. Howard G et al. for the IRAS Investigators. Insulin sensitivity and atherosclerosis Circulation 1996; 93: 1809–1817

    Article  CAS  Google Scholar 

  29. DeMeersman RE et al. Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women Am J Physiol 1998; 274: H1539–H1544

    CAS  Google Scholar 

  30. Mendelsohn ME, Karas RH . Mechanisms of disease: the protective effects of estrogen on the cardiovascular system N Engl J Med 1999; 340: 1801–1811

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I Cardiac Department, Jagiellonian University Medical College, Krakow, Poland

    K Kawecka-Jaszcz, D Czarnecka, A Olszanecka, M Rajzer & P Jankowski

Authors
  1. K Kawecka-Jaszcz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Czarnecka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Olszanecka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Rajzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Jankowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Kawecka-Jaszcz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawecka-Jaszcz, K., Czarnecka, D., Olszanecka, A. et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 16, 509–516 (2002). https://doi.org/10.1038/sj.jhh.1001431

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001431

Keywords

This article is cited by

Search

Advanced search

Quick links